[Remote] Regional Sales Manager, Southern California at Tempus

California, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Deep domain knowledge of the Diagnostic Services industry
Molecular Diagnostic experience strongly preferred
Experience selling Oncology based tests and services into the Pathology and/or Oncology clinical communities preferred
Experience within complex selling environments required
Demonstrated success in recruiting, hiring, developing and retaining talent

Responsibilities

Achievement of regional sales objectives; revenue and expenses
Development and execution of a regional and territory business plans
Direct execution of sales strategies and tactics, and implementation of sales and marketing plans
Develop and maintain key customer relationships with target audiences; assist in developing business solutions that are mutually beneficial
Plan and conduct regional sales meetings designed to inform and convey existing and new product knowledge and applications and enhance and develop sales and business skills
Evaluate performance of Clinical Account Executives
Maintain high level of product and market knowledge
Identify contracting opportunities with academic medical centers, large cancer centers, health systems, and other strategically important key accounts
Management oversight of Tempus’s CRM solution for the defined geographic region
Work collaboratively with cross-functional partners to access resources and maximize outcomes

Skills

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free